Medidrug® DOA-I S
Lyophilized serum based reference material for quality assurance of the determination of drugs of abuse. The indicated target values are determined by independent accredited laboratories; the determinations themselves are respecting the guidelines RiLiBÄK (by the German Medical Association) and those by the GTFCh (Society for Toxicology and Forensic Chemistry in Germany).
Medidrug® Basis-line S
Lyophilized reference material for base line determination in different applications or as negative control.
| Product group overview | ||||||
| Medidrug® | | | DOA-I S | Basis-line S | ||
| | | | 34 / 35 analytes | 91 analytes | ||
| | | | Low | Mid | High | Negative |
| Group | Analyte | Einheit | target values | |||
| Amine/Amphetamines | Amphetamine | µg/l | 25 | 90 | 150 | < LOD |
| | MBDB | µg/l | 25 | 60 | 100 | < LOD |
| | MDA | µg/l | 25 | 60 | 100 | < LOD |
| | MDE (MDEA) | µg/l | 25 | 90 | 150 | < LOD |
| | MDMA ("Ecstasy") | µg/l | 25 | 90 | 150 | < LOD |
| | Methamphetamine | µg/l | 25 | 90 | 150 | < LOD |
| | Methylphenidate | µg/l | 10 | 30 | 60 | < LOD |
| Cannabinoids | CBD (Cannabidiol) | µg/l | 5 | - | 100 | < LOD |
| | THC | µg/l | 1 | 10 | 15 | < LOD |
| | 11-OH-THC | µg/l | 1 | 5 | 10 | < LOD |
| | THC-COOH | µg/l | 10 | 60 | 120 | < LOD |
| Cathinone | Mephedrone | µg/l | 25 | 90 | 150 | < LOD |
| | Methedrone | µg/l | 25 | 90 | 150 | < LOD |
| | Methylone | µg/l | 25 | 90 | 150 | < LOD |
| Cocaine | Cocaine | µg/l | 15 | 50 | 90 | < LOD |
| | Benzoylecgonine (BE) | µg/l | 50 | 200 | 400 | < LOD |
| | Cocaethylene | µg/l | 10 | 60 | 100 | < LOD |
| | Ecgonine methyl ester | µg/l | 15 | 50 | 90 | < LOD |
| Opioids | 6-MAM | µg/l | 5 | 25 | 50 | < LOD |
| | Codeine | µg/l | 10 | 60 | 100 | < LOD |
| | Dihydrocodeine (DHC) | µg/l | 40 | 100 | 200 | < LOD |
| | Ethylmorphine | µg/l | 40 | 90 | 200 | < LOD |
| | Fentanyl | µg/l | 1 | 5 | 10 | < LOD |
| | Norfentanyl | µg/l | 1 | 5 | 10 | < LOD |
| | Hydrocodone | µg/l | 10 | 60 | 100 | < LOD |
| | Hydromorphone | µg/l | 10 | 60 | 100 | < LOD |
| | Morphine | µg/l | 10 | 60 | 100 | < LOD |
| | Oxycodone | µg/l | 10 | 60 | 100 | < LOD |
| | Oxymorphone | µg/l | 10 | 60 | 100 | < LOD |
| | Pholcodine | µg/l | 25 | 90 | 150 | < LOD |
| | Tilidine | µg/l | 25 | 90 | 150 | < LOD |
| | Nortilidine | µg/l | 25 | 90 | 150 | < LOD |
| | Tramadol | µg/l | 50 | 100 | 200 | < LOD |
| | o-Desmethyltramadol | µg/l | 100 | 200 | 400 | < LOD |
| Piperazines | Benzylpiperazine | µg/l | 10 | 60 | 100 | < LOD |
| | ||||||
Medidrug® DOA-I VB
Lyophilized reference material based on whole blood for quality assurance of the determination of drugs of abuse. The indicated target values are determined by independent accredited laboratories; the determinations themselves are respecting the guidelines RiLiBÄK (by the German Medical Association) and those by the GTFCh (Society for Toxicology and Forensic Chemistry in Germany).
Medidrug® Basis-line VB
Lyophilized reference material for base line determination in different applications or as negative control.
| Product group overview | ||||||
| Medidrug® | | | DOA-I VB | Basis-line VB | ||
| | | | 34 / 35 analytes | 76 analytes | ||
| | | | Low | Mid | High | Negative |
| Group | Analyte | Unit | target values | |||
| Amines/Amphetamines | Amphetamine | µg/l | 25 | 90 | 150 | < LOD |
| | MBDB | µg/l | 25 | 60 | 100 | < LOD |
| | MDA | µg/l | 25 | 60 | 100 | < LOD |
| | MDE (MDEA) | µg/l | 25 | 90 | 150 | < LOD |
| | MDMA ("Ecstasy") | µg/l | 25 | 90 | 150 | < LOD |
| | Methamphetamine | µg/l | 25 | 90 | 150 | < LOD |
| | Methylphenidate | µg/l | 10 | 30 | 60 | < LOD |
| Cannabinoids | CBD (Cannabidiol) | µg/l | - | 25 | - | < LOD |
| | THC | µg/l | 1 | 10 | 15 | <LOD |
| | 11-OH-THC | µg/l | 1 | 10 | 10 | < LOD |
| | THC-COOH | µg/l | 10 | 60 | 120 | < LOD |
| Cathinone | Mephedrone | µg/l | 25 | 90 | 150 | < LOD |
| | Methedrone | µg/l | 25 | 90 | 150 | < LOD |
| | Methylone | µg/l | 25 | 90 | 150 | < LOD |
| Cocaine | Cocaine | µg/l | 15 | 50 | 90 | < LOD |
| | Benzoylecgonine | µg/l | 50 | 200 | 400 | < LOD |
| | Cocaethylene | µg/l | 10 | 60 | 100 | < LOD |
| | Ecgonine methyl ester | µg/l | 15 | 50 | 90 | < LOD |
| Opioids | 6-MAM | µg/l | 5 | 25 | 50 | < LOD |
| | Codeine | µg/l | 10 | 60 | 100 | < LOD |
| | Dihydrocodeine (DHC) | µg/l | 40 | 100 | 200 | < LOD |
| | Ethylmorphine | µg/l | 35 | 100 | 180 | < LOD |
| | Fentanyl | µg/l | 1 | 5 | 10 | < LOD |
| | Norfentanyl | µg/l | 1 | 5 | 10 | < LOD |
| | Hydrocodone | µg/l | 10 | 60 | 100 | < LOD |
| | Hydromorphone | µg/l | 10 | 60 | 100 | < LOD |
| | Morphine | µg/l | 10 | 60 | 100 | < LOD |
| | Oxycodone | µg/l | 10 | 60 | 100 | < LOD |
| | Oxymorphone | µg/l | 10 | 60 | 100 | < LOD |
| | Pholcodine | µg/l | 25 | 90 | 150 | < LOD |
| | Tilidine | µg/l | 25 | 90 | 150 | < LOD |
| | Nortilidine | µg/l | 25 | 90 | 150 | < LOD |
| | Tramadol | µg/l | 50 | 100 | 200 | < LOD |
| | o-Desmethyltramadol | µg/l | 100 | 200 | 400 | < LOD |
| Piperazines | Benzylpiperazine | µg/l | 10 | 60 | 100 | < LOD |
| | ||||||
Medidrug® DOA-I VB
Lyophilized reference material based on whole blood for quality assurance of the determination of drugs of abuse. The indicated target values are determined by independent accredited laboratories; the determinations themselves are respecting the guidelines RiLiBÄK (by the German Medical Association) and those by the GTFCh (Society for Toxicology and Forensic Chemistry in Germany).
Medidrug® Basis-line VB
Lyophilized reference material for base line determination in different applications or as negative control.
| Product group overview | ||||||
| Medidrug® | | | DOA-I VB | Basis-line VB | ||
| | | | 38 analytes | 76 analytes | ||
| | | | Low | Mid | High | Negative |
| Group | Analyte | Einheit | Zielwerte | |||
| Amines/Amphetamines | Amphetamine | µg/l | 25 | 90 | 150 | < LOD |
| | MBDB | µg/l | 25 | 60 | 100 | < LOD |
| | MDA | µg/l | 25 | 60 | 100 | < LOD |
| | MDE (MDEA) | µg/l | 25 | 90 | 150 | < LOD |
| | MDMA | µg/l | 25 | 90 | 150 | < LOD |
| | Methamphetamine | µg/l | 25 | 90 | 150 | < LOD |
| | Methylphenidate | µg/l | 10 | 33 | 60 | < LOD |
| Cannabinoids | CBD (Cannabidiol) (NEW) | µg/l | 5 | 25 | 100 | < LOD |
| | THC | µg/l | 1 | 10 | 15 | < LOD |
| | 11-OH-THC | µg/l | 1 | 10 | 15 | < LOD |
| | THC-COOH | µg/l | 10 | 50 | 100 | < LOD |
| Cathinone | Mephedrone | µg/l | 25 | 90 | 150 | < LOD |
| | Methedrone | µg/l | 25 | 90 | 150 | < LOD |
| | Methylone | µg/l | 25 | 90 | 150 | < LOD |
| Cocaine | Cocaine | µg/l | 15 | 50 | 90 | < LOD |
| | Benzoylecgonine | µg/l | 25 | 82 | 400 | < LOD |
| | Cocaethylene | µg/l | 10 | 60 | 100 | < LOD |
| | Ecgonin methyl ester | µg/l | 15 | 50 | 90 | < LOD |
GHB | 4 hydroxy-butanoic acid (NEW) | mg/l | 1 | 5 | 20 | < LOD |
| Opioids | 6-MAM | µg/l | 5 | 25 | 50 | < LOD |
| | Codeine | µg/l | 10 | 60 | 100 | < LOD |
| | Dihydrocodeine (DHC) | µg/l | 30 | 100 | 200 | < LOD |
| | Ethylmorphine | µg/l | 30 | 100 | 200 | < LOD |
| | Fentanyl | µg/l | 1 | 5 | 10 | < LOD |
| | Norfentanyl | µg/l | 1 | 5 | 10 | < LOD |
| | Hydrocodone | µg/l | 10 | 60 | 100 | < LOD |
| | Hydromorphone | µg/l | 10 | 60 | 100 | < LOD |
| | Morphine | µg/l | 10 | 60 | 100 | < LOD |
| | Oxycodone | µg/l | 10 | 60 | 100 | < LOD |
| | Oxymorphone | µg/l | 10 | 60 | 100 | < LOD |
| | Pholcodine | µg/l | 25 | 90 | 150 | < LOD |
| | Tilidine | µg/l | 25 | 90 | 150 | < LOD |
| | Nortilidine | µg/l | 25 | 90 | 150 | < LOD |
| | Tramadol | µg/l | 50 | 100 | 200 | < LOD |
| | o-Desmethyltramadol | µg/l | 100 | 200 | 400 | < LOD |
| | Ketamine (NEW) | µg/l | 5 | 25 | 100 | < LOD |
| | Norketamine (NEW) | µg/l | 5 | 25 | 100 | < LOD |
| Piperazines | Benzylpiperazine | µg/l | 10 | 60 | 100 | < LOD |
| | ||||||
Medidrug® DOA H-d
Lot series of extremely homogeneous hair reference materials in six relevant concentration levels, prepared from four meticulously homogenized drug-free hair pools of cut European human hair. Spiked gravimetrically with 64 drugs of abuse and their metabolites, we have considered relevant limits of quantification or detection (method-dependent) and cut-off ranges (by German and various international professional societies). The homogeneity has been controlled under repetitive conditions.
| Product group overview | ||||||||
| Medidrug® | | | DOA H-d | |||||
| | | | 64 analytes | |||||
| | | | L0 | L1 | L2 | L3 | L4 | L5 |
| Group | Analyte | Unit | target values | |||||
| Amphetamines | Amphetamine | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | MBDB | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | MDA | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | MDE(A) | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | MDMA | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | Methamphetamine | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | Methylphenidate | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | Phentermine | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| Benzodiazepines + Z- Drugs | Alprazolam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | OH-Alprazolam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | 7-Aminoclon- azepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | 7-Aminoflunitr azepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Bromazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Clonazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Diazepam (Valium) | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Desmethyl (Nor-)diazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Flunitrazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Flurazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Lorazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Lormetazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Midazolam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Nitrazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Oxazepam | pg/mg | 0 | 2 | 24 | 6 | 240 | 960 |
| | Temazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Tetrazepam | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Zolpidem | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| | Zopiclon | pg/mg | 0 | 2 | 24 | 60 | 240 | 960 |
| Cannabinoides | THC | pg/mg | 0 | 12 | 24 | 60 | 120 | 720 |
| | CBD (Cannabidiol) | pg/mg | 0 | 24 | 60 | 120 | 240 | 720 |
| | CBN (Cannabinol) | pg/mg | 0 | 24 | 60 | 120 | 240 | 720 |
| | THC-COOH | pg/mg | 0 | 0 | 1 | 2 | 6 | 12 |
| | 11-OH-THC | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| Cocaine | Anhydroecgonine methyl ester | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| | Benzoylecgonine | pg/mg | 0 | 24 | 60 | 200 | 750 | 3.000 |
| | Cocaethylene | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| | Cocaine | pg/mg | 0 | 60 | 120 | 600 | 1.200 | 8.400 |
| | Ecgonine methyl ester | pg/mg | 0 | 24 | 60 | 150 | 750 | 3.000 |
| | Norcocaine | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
Hallucinogens | Ketamine | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| | Norketamine | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| | LSD | pg/mg | 0 | 6 | 12 | 60 | 150 | 720 |
| | Phencyclidine | pg/mg | 0 | 24 | 60 | 150 | 750 | 3.000 |
| Opioids | Codeine | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | Acetylcodeine | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | Dihydrocodeine | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | Fentanyl | pg/mg | 0 | 6 | 12 | 60 | 150 | 720 |
| | Hydrocodone | pg/mg | 0 | 24 | 60 | 120 | 240 | 720 |
| | Hydromorphone | pg/mg | 0 | 24 | 60 | 120 | 240 | 720 |
| | Morphine | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | 6-MAM | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | Norfentanyl | pg/mg | 0 | 1 | 6 | 30 | 180 | 720 |
| | Oxycodone | pg/mg | 15 | 50 | 70 | 120 | 240 | 720 |
| | Oxymorphone | pg/mg | 0 | 24 | 60 | 120 | 240 | 720 |
| | Pregabalin | pg/mg | 0 | 12 | 24 | 120 | 600 | 1.800 |
| | Tilidine | pg/mg | 0 | 24 | 60 | 120 | 240 | 720 |
| | Nortilidine | pg/mg | 0 | 24 | 60 | 120 | 240 | 720 |
| | Tapentadol | pg/mg | 0 | 24 | 60 | 120 | 240 | 1.800 |
| | Tramadol | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| | N-Desmethyl-Tramadol | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| | O-Desmethyl-cis-Tramadol | pg/mg | 0 | 24 | 60 | 120 | 600 | 1.800 |
| Substitution for Opioids | Buprenorphine | pg/mg | 0 | 6 | 12 | 60 | 150 | 720 |
| | Norbuprenorphine | pg/mg | 0 | 6 | 12 | 60 | 150 | 720 |
| | Methadone | pg/mg | 0 | 70 | 140 | 270 | 650 | 1.800 |
| | EDDP | pg/mg | 0 | 24 | 60 | 150 | 750 | 3.000 |
| | ||||||||
Medidrug® CTU Confirm. U
Lyophilized reference material for quality control of confirmation analysis, prepared from human urine. The concentrations of the added substances for chemical-toxicological analysis -CTU1)- are -25 % respectively +25 % of the recommended cut-offs. Further substances and their target values suit to the CTU criteria2). All target values are determined by independent accredited laboratories.
Medidrug® Basis-line U
Lyophilized reference material, prepared from human urine for base-line determination in different applications or as negative control.
| Product group overview | |||||
| Medidrug® | | | CTU Confirm. U | Basis-line U | |
| | | | 59 analytes | 79 analytes | |
| | | | Cut-off -25% | Cut-off +25% | Negative |
| Group | Analyte | Unit | target values | ||
| Alcohols | Ethyl glucuronide | µg/l | 75 | 125 | < LOD |
| | Ethyl sulfate* | µg/l | 75 | 125 | < LOD |
| Amphetamines | Amphetamine | µg/l | 37,5 | 62,5 | < LOD |
| | MBDB* | µg/l | 37,5 | 62,5 | < LOD |
| | MDA | µg/l | 37,5 | 62,5 | < LOD |
| | MDE | µg/l | 37,5 | 62,5 | < LOD |
| | MDMA | µg/l | 37,5 | 62,5 | < LOD |
| | Methamphetamine | µg/l | 37,5 | 62,5 | < LOD |
| Barbiturates | Phenobarbital* | µg/l | 22,5 | 37,5 | < LOD |
| | Secobarbital* | µg/l | 22,5 | 37,5 | < LOD |
Benzodiazepines and Z-Drugs | Alprazolam* | µg/l | 37,5 | 62,5 | < LOD |
| | OH-Alprazolam | µg/l | 37,5 | 62,5 | < LOD |
| | Bromazepam | µg/l | 37,5 | 62,5 | < LOD |
| | OH-Bromazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Clonazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | 7-Aminoclonazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Diazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Desmethyl(Nor-)diazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Flunitrazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | 7-Aminoflunitrazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Flurazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Lorazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Lormetazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Midazolam* | µg/l | 37,5 | 62,5 | < LOD |
| | Nitrazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Oxazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Phenazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Temazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Zaleplon* | µg/l | 37,5 | 62,5 | < LOD |
| | Zolpidem | µg/l | 37,5 | 62,5 | < LOD |
| | Zopiclone* | µg/l | 37,5 | 62,5 | < LOD |
| Cannabinoid | THC-COOH | µg/l | 7,5 | 12,5 | < LOD |
| Cathinones | Mephedrone* | µg/l | 37,5 | 62,5 | < LOD |
| | Methylendioxypyrovalerone* | µg/l | 37,5 | 62,5 | < LOD |
| Cocaine | Benzoylecgonine | µg/l | 22,5 | 37,5 | < LOD |
| | Ecgonine methyl ester* | µg/l | 22,5 | 37,5 | < LOD |
| Hallucinogenes | Ketamine* | µg/l | 37,5 | 62,5 | < LOD |
| | LSD* | µg/l | 0,38 | 0,63 | < LOD |
| | Methaqualone* | µg/l | 18,75 | 31,25 | < LOD |
| | Phencyclidine* | µg/l | 18,75 | 31,25 | < LOD |
| Opioids | 6-MAM* | µg/l | 7,5 | 12,5 | < LOD |
| | Codeine | µg/l | 18,75 | 31,25 | < LOD |
| | Dihydrocodeine | µg/l | 18,75 | 31,25 | < LOD |
| | Norcodeine* | µg/l | 37,5 | 62,5 | - |
| | Fentanyl | µg/l | 7,5 | 12,5 | < LOD |
| | Norfentanyl | µg/l | 7,5 | 12,5 | < LOD |
| | Hydromorphone* | µg/l | 37,5 | 62,5 | < LOD |
| | Morphine | µg/l | 18,75 | 31,25 | < LOD |
| | Oxycodone | µg/l | 37,5 | 62,5 | < LOD |
| | Oxymorphone* | µg/l | 37,5 | 62,5 | < LOD |
| | Propoxyphene* | µg/l | 18,75 | 31,25 | < LOD |
| | Tilidine | µg/l | 37,5 | 62,5 | < LOD |
| | Nortilidine* | µg/l | 48,75 | 81,25 | < LOD |
| | Tramadol | µg/l | 37,5 | 62,5 | < LOD |
| | O-Desmethyltramadol | µg/l | 37,5 | 62,5 | < LOD |
| Substitution for Opioids | Buprenorphine* | µg/l | 1,5 | 2,5 | < LOD |
| | Norbuprenorphine* | µg/l | 1,5 | 2,5 | < LOD |
| | Methadone | µg/l | 37,5 | 62,5 | < LOD |
| | EDDP | µg/l | 37,5 | 62,5 | < LOD |
| | |||||
*)CTU: Chemical-toxicological analysis: Evaluation for driving fitness (guidelines DGVP & DGVM in Germany);
according to this
Medidrug® CTU Confirm. U
Lyophilized reference material for quality control of confirmation analysis, prepared from human urine. The concentrations of the added substances for chemical-toxicological analysis -CTU1)- are -25 % respectively +25 % of the recommended cut-offs. Further substances and their target values suit to the CTU criteria2). All target values are determined by independent accredited laboratories.
Medidrug® Basis-line U
Lyophilized reference material, prepared from human urine for base-line determination in different applications or as negative control.
| Product group overview | |||||
| Medidrug® | | | CTU Confirm U | Basis-line U | |
| | | | 65 analytes | 79 analytes | |
| | | | Cut-off -25% | Cut-off +25% | Negative |
| Group | Analyte | Unit | target value | ||
| Alcohols | Ethyl glucuronide | µg/l | 75 | 125 | < LOD |
| | Ethyl sulfate* | µg/l | 56,25 | 93,75 | < LOD |
| Amphetamines | Amphetamine | µg/l | 22,5 | 37,5 | < LOD |
| | MBDB* | µg/l | 37,5 | 62,5 | < LOD |
| | MDA | µg/l | 37,5 | 62,5 | < LOD |
| | MDEA | µg/l | 37,5 | 62,5 | < LOD |
| | MDMA | µg/l | 37,5 | 62,5 | < LOD |
| | Methamphetamine | µg/l | 22,5 | 37,5 | < LOD |
| Barbiturates | Amobarbital* - NEU | µg/l | 22,5 | 37,5 | < LOD |
| | Pentobarbital* - NEU | µg/l | 22,5 | 37,5 | < LOD |
| | Phenobarbital* | µg/l | 22,5 | 37,5 | < LOD |
| | Secobarbital* | µg/l | 22,5 | 37,5 | < LOD |
| Benzodiazepines and Z-Drugs | Alprazolam | µg/l | 37,5 | 62,5 | < LOD |
| | Alpha-Hydroxyalprazolam | µg/l | 37,5 | 62,5 | < LOD |
| | Bromazepam | µg/l | 37,5 | 62,5 | < LOD |
| | 3-Hydroxybromazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Clonazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | 7-Aminoclonazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Diazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Desmethyl(Nor-)diazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Flunitrazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | 7-Aminoflunitrazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Flurazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Lorazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Lormetazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Midazolam* | µg/l | 37,5 | 62,5 | < LOD |
| | Nitrazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Oxazepam | µg/l | 37,5 | 62,5 | < LOD |
| | Phenazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Temazepam* | µg/l | 37,5 | 62,5 | < LOD |
| | Zaleplon* | µg/l | 37,5 | 62,5 | < LOD |
| | Zolpidem* | µg/l | 37,5 | 62,5 | < LOD |
| | Zopiclon* | µg/l | 37,5 | 62,5 | < LOD |
| Cannabinoides | THC-COOH | µg/l | 5,6 | 9,3 | < LOD |
| | CBD* - NEW | µg/l | 5,6 | 9,3 | < LOD |
| Cathinones | Mephedrone* | µg/l | 37,5 | 62,5 | < LOD |
| | Methylendioxypyrovalerone* | µg/l | 37,5 | 62,5 | < LOD |
| Cocaine | Benzoylecgonine | µg/l | 22,5 | 37,5 | < LOD |
| | Ecgonine methyl ester* | µg/l | 22,5 | 37,5 | < LOD |
| Halluzinogens | Ketamine* | µg/l | 37,5 | 62,5 | < LOD |
| | LSD* | µg/l | 0,38 | 0,63 | < LOD |
| | Methaqualone* | µg/l | 18,75 | 31,25 | < LOD |
| | Phencyclidine* | µg/l | 18,75 | 31,25 | < LOD |
| Opioids | 6-MAM* | µg/l | 7,5 | 12,5 | < LOD |
| | Codeine | µg/l | 18,75 | 31,25 | < LOD |
| | Dihydrocodeine | µg/l | 18,75 | 31,25 | < LOD |
| | Norcodeine* | µg/l | 37,5 | 62,5 | < LOD |
| | Fentanyl | µg/l | 7,5 | 12,5 | < LOD |
| | Norfentanyl | µg/l | 7,5 | 12,5 | < LOD |
| | Hydrocodon - NEW | µg/l | 37,5 | 62,5 | < LOD |
| | Hydromorphone* | µg/l | 37,5 | 62,5 | < LOD |
| | Morphine | µg/l | 18,75 | 31,25 | < LOD |
| | Oxycodone | µg/l | 37,5 | 62,5 | < LOD |
| | Oxymorphone* | µg/l | 37,5 | 62,5 | < LOD |
| | Propoxyphene* | µg/l | 18,75 | 31,25 | < LOD |
| | d-Norpropoxyphene* - NEW | µg/l | 18,75 | 31,25 | < LOD |
| | Tilidine | µg/l | 37,5 | 62,5 | < LOD |
| | Nortilidine | µg/l | 48,75 | 81,25 | < LOD |
| | Tramadol | µg/l | 37,5 | 62,5 | < LOD |
| | O-Desmethyltramadol | µg/l | 37,5 | 62,5 | < LOD |
| Substitution for Opioids | Buprenorphine | µg/l | 1,5 | 2,5 | < LOD |
| | Norbuprenorphine | µg/l | 0,75 | 1,25 | < LOD |
| | Methadon | µg/l | 22,5 | 37,5 | < LOD |
| | EDDP | µg/l | 22,5 | 37,5 | < LOD |
| Piperazines | Benzylpiperazine* - NEW | µg/l | 37,5 | 62,5 | < LOD |
| | |||||
*)CTU: Chemical-toxicological analysis: Evaluation for driving fitness (guidelines DGVP & DGVM in Germany); according to this
Medidrug® WDT Confirm. U
Lyophilized urine control, prepared from human urine containing drugs and medicaments. The concentrations of the added substances are -25 % respectively +25 % of the recommended cut-off by EWDTS1) for confirmation test. The target values of further analytes suit to the EWDTS guidelines2). All target values are determined by independent accredited laboratories.
Medidrug® Basis-line U
Lyophilized reference material, prepared from human urine for base-line determination in different applications or as negative control.
| Product group overview | |||||
| Medidrug® | | | WDT Confirm. U | Basis-line U | |
| | | | 59 analytes | 79 analytes | |
| | | | Cut-off -25% | Cut-off +25% | Negative |
| Group | Analyte | Unit | target values | ||
| Amphetamine | Amphetamin | µg/l | 150 | 250 | < LOD |
| | MBDB | µg/l | 150 | 250 | < LOD |
| | MDA | µg/l | 150 | 250 | < LOD |
| | MDE (MDEA) | µg/l | 150 | 250 | < LOD |
| | MDMA ("Ecstasy") | µg/l | 150 | 250 | < LOD |
| | Methamphetamine | µg/l | 150 | 250 | < LOD |
| Barbiturates | Phenobarbital | µg/l | 112,5 | 187,5 | < LOD |
| | Secobarbital | µg/l | 112,5 | 187,5 | < LOD |
Benzodiazepines and Z-Drugs | Alprazolam | µg/l | 75 | 125 | < LOD |
| | OH-Alprazolam* | µg/l | 75 | 125 | < LOD |
| | Bromazepam | µg/l | 75 | 125 | < LOD |
| | OH-Bromazepam* | µg/l | 75 | 125 | < LOD |
| | Clonazepam | µg/l | 75 | 125 | < LOD |
| | 7-Aminoclonazepam | µg/l | 75 | 125 | < LOD |
| | Diazepam | µg/l | 75 | 125 | < LOD |
| | N-Desmethyl(Nor-)diazepam | µg/l | 75 | 125 | < LOD |
| | Flunitrazepam | µg/l | 75 | 125 | < LOD |
| | 7-Aminoflunitrazepam* | µg/l | 75 | 125 | < LOD |
| | Flurazepam | µg/l | 75 | 125 | < LOD |
| | Lorazepam | µg/l | 75 | 125 | < LOD |
| | Lormetazepam | µg/l | 75 | 125 | < LOD |
| | Midazolam | µg/l | 75 | 125 | < LOD |
| | Nitrazepam | µg/l | 75 | 125 | < LOD |
| | Oxazepam | µg/l | 75 | 125 | < LOD |
| | Phenazepam | µg/l | 75 | 125 | < LOD |
| | Temazepam | µg/l | 75 | 125 | < LOD |
| | Zaleplon* | µg/l | 75 | 125 | < LOD |
| | Zolpidem* | µg/l | 75 | 125 | < LOD |
| | Zopiclone* | µg/l | 75 | 125 | < LOD |
| Cannabinoid | THC-COOH | µg/l | 11,25 | 18,75 | < LOD |
| Cathinones | Mephedrone* | µg/l | 150 | 250 | < LOD |
| | Methylendioxypyrovalerone* | µg/l | 150 | 250 | < LOD |
| Cocaine | Benzoylecgonine | µg/l | 75 | 125 | < LOD |
| | Ecgonine methyl ester | µg/l | 75 | 125 | < LOD |
| Hallucinogens | Ketamine* | µg/l | 150 | 250 | < LOD |
| | LSD | µg/l | 0,75 | 1,25 | < LOD |
| | Methaqualone* | µg/l | 225 | 375 | < LOD |
| | Phencyclidine | µg/l | 18,75 | 31,25 | < LOD |
| Opioids | 6-MAM | µg/l | 7,5 | 12,5 | < LOD |
| | Codeine | µg/l | 225 | 375 | < LOD |
| | Dihydrocodeine | µg/l | 225 | 375 | < LOD |
| | Norcodeine* | µg/l | 37,5 | 62,5 | - |
| | Fentanyl* | µg/l | 7,5 | 12,5 | < LOD |
| | Norfentanyl* | µg/l | 7,5 | 12,5 | < LOD |
| | Hydromorphone* | µg/l | 75 | 125 | < LOD |
| | Morphine | µg/l | 225 | 375 | < LOD |
| | Morphin-3-ß-D-glucuronide* | µg/l | 225 | 375 | < LOD |
| | Oxycodone* | µg/l | 75 | 125 | < LOD |
| | Oxymorphone* | µg/l | 75 | 125 | < LOD |
| | Pregabalin* | µg/l | 750 | 1.250 | < LOD |
| | Propoxyphene | µg/l | 225 | 375 | < LOD |
| | Tilidine* | µg/l | 150 | 250 | < LOD |
| | Nortilidine* | µg/l | 75 | 125 | < LOD |
| | Tramadol* | µg/l | 75 | 125 | < LOD |
| | O-Desmethyltramadol* | µg/l | 75 | 125 | < LOD |
Substitution for Opioids | Buprenorphine | µg/l | 1,5 | 2,5 | < LOD |
| | Norbuprenorphine | µg/l | 1,5 | 2,5 | < LOD |
| | Methadone | µg/l | 187,5 | 312,5 | < LOD |
| | EDDP | µg/l | 56,25 | 93,75 | < LOD |
| | |||||
*)EWDTS - European Workplace Drug Testing Society - 2015 European Guidelines for Workplace Drug Testing in Urine (pp 37-40); in Anlehnung daran.
Medidrug® WDT Confirm. U
Lyophilized urine control, prepared from human urine containing drugs and medicaments. The concentrations of the added substances are -25 % respectively +25 % of the recommended cut-off by EWDTS1) for confirmation test. The target values of further analytes suit to the EWDTS guidelines2). All target values are determined by independent accredited laboratories.
Medidrug® Basis-line U
Lyophilized reference material, prepared from human urine for base-line determination in different applications or as negative control.
Products group overview | |||||
Medidrug® | WDT Confirm U | Basis-line U | |||
| 66 analytes | 79 analytes | ||||
| Cut-off -25% | Cut-off +25% | Negative | |||
Groups | Analyte | Unit | target values | ||
Amphetamines | Amphetamine | µg/l | 150 | 250 | < LOD |
MBDB | µg/l | 150 | 250 | < LOD | |
MDA | µg/l | 150 | 250 | < LOD | |
MDE (MDEA) | µg/l | 150 | 250 | < LOD | |
MDMA ("Ecstasy") | µg/l | 150 | 250 | < LOD | |
Methamphetamin | µg/l | 150 | 250 | < LOD | |
Barbiturates | Amobarbital - NEW | µg/l | 112,5 | 187,5 | < LOD |
Pentobarbital - NEW | µg/l | 112,5 | 187,5 | < LOD | |
Phenobarbital | µg/l | 112,5 | 187,5 | < LOD | |
Secobarbital | µg/l | 112,5 | 187,5 | < LOD | |
Benzodiazepinse and Z-Drugs | Alprazolam | µg/l | 75 | 125 | < LOD |
α-Hydroxyalprazolam | µg/l | 75 | 125 | < LOD | |
Bromazepam | µg/l | 75 | 125 | < LOD | |
3-Hydrobromazepam* | µg/l | 75 | 125 | < LOD | |
Clonazepam | µg/l | 75 | 125 | < LOD | |
7-Aminoclonazepam | µg/l | 75 | 125 | < LOD | |
Diazepam | µg/l | 75 | 125 | < LOD | |
N-Desmethyl(Nor-)diazepam | µg/l | 75 | 125 | < LOD | |
Flunitrazepam | µg/l | 75 | 125 | < LOD | |
7-Aminoflunitrazepam | µg/l | 75 | 125 | < LOD | |
Flurazepam | µg/l | 75 | 125 | < LOD | |
Lorazepam | µg/l | 75 | 125 | < LOD | |
Lormetazepam | µg/l | 75 | 125 | < LOD | |
Midazolam | µg/l | 75 | 125 | < LOD | |
Nitrazepam | µg/l | 75 | 125 | < LOD | |
Oxazepam | µg/l | 75 | 125 | < LOD | |
Phenazepam | µg/l | 75 | 125 | < LOD | |
Temazepam | µg/l | 75 | 125 | < LOD | |
Zaleplon | µg/l | 75 | 125 | < LOD | |
Zolpidem | µg/l | 75 | 125 | < LOD | |
Zopiclon | µg/l | 75 | 125 | < LOD | |
Cannabinoids | THC-COOH | µg/l | 11,25 | 18,75 | < LOD |
Cathinones | Mephedrone* | µg/l | 150 | 250 | < LOD |
Methylendioxypyrovalerone* | µg/l | 150 | 250 | < LOD | |
Cocaine | Benzoylecgonine | µg/l | 75 | 125 | < LOD |
Ecgonine methyl ester* | µg/l | 75 | 125 | < LOD | |
Hallucinogens | Ketamine* | µg/l | 55 | 95 | < LOD |
LSD | µg/l | 0,75 | 1,25 | < LOD | |
Norketamine* | µg/l | 55 | 95 | < LOD | |
Methaqualone* | µg/l | 225 | 375 | < LOD | |
Phencyclidine | µg/l | 18,75 | 31,25 | < LOD | |
Opioids | 6-MAM | µg/l | 7,5 | 12,5 | < LOD |
Codeine | µg/l | 225 | 375 | < LOD | |
Dihydrocodeine | µg/l | 225 | 375 | < LOD | |
Norcodeine* | µg/l | 37,5 | 62,5 | - | |
Fentanyl | µg/l | 0,75 | 1,25 | < LOD | |
Norfentanyl* | µg/l | 0,75 | 1,25 | < LOD | |
Gabapentine - NEW | µg/l | 750 | 1250 | ||
Hydromorphone | µg/l | 75 | 125 | < LOD | |
Morphine | µg/l | 225 | 375 | < LOD | |
Morphin-3-ß-D-glucuronide* | µg/l | 225 | 375 | < LOD | |
Hydrocodone - NEW | µg/l | 75 | 125 | ||
Oxycodone | µg/l | 75 | 125 | < LOD | |
Oxymorphone | µg/l | 75 | 125 | < LOD | |
Pregabalin | µg/l | 187,5 | 312,5 | < LOD | |
Propoxyphene | µg/l | 225 | 375 | < LOD | |
Norpropoxyphene - NEW | µg/l | 225 | 375 | < LOD | |
Tilidine* | µg/l | 150 | 250 | < LOD | |
Nortilidine* | µg/l | 75 | 125 | < LOD | |
Tramadol | µg/l | 75 | 125 | < LOD | |
O-Desmethyltramadol | µg/l | 75 | 125 | < LOD | |
Substitution for Opiods | Buprenorphine | µg/l | 1,5 | 2,5 | < LOD |
Norbuprenorphine | µg/l | 1,5 | 2,5 | < LOD | |
Methadone | µg/l | 187,5 | 312,5 | < LOD | |
EDDP | µg/l | 56,25 | 93,75 | < LOD | |
Piperazine | Benzylpiperazine* - NEW | µg/l | 150 | 250 | < LOD |
*)EWDTS - European Workplace Drug Testing Society - 2022 European Guidelines for Workplace Drug Testing in Urine (pp 39-40); in Anlehnung daran.